Enlivex Therapeutics
ENLV
ENLV
16 hedge funds and large institutions have $409K invested in Enlivex Therapeutics in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.
Holders
16
Holders Change
-3
Holders Change %
-15.79%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
4
Closed
4
Calls
$48K
Puts
$8K
Net Calls
+$40K
Net Calls Change
-$105K
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$93K |
2 |
2
Morgan Stanley
New York
|
$69.8K |
3 |
3
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$2 |